O
Orpyx Medical Technologies
Empowers people with diabetes to maintain mobility
About Orpyx Medical Technologies
Orpyx Medical Technologies Inc. specializes in developing advanced wearable sensor technologies aimed at preventing diabetic foot ulcers and limb loss. The company operates in the healthcare market, focusing on individuals with diabetic peripheral neuropathy, a condition that can lead to severe foot complications. Orpyx's flagship product, the Orpyx SI Sensory Insoles, incorporates sensors to monitor pressure, temperature, and movement, providing real-time feedback to users and healthcare providers. This technology has demonstrated an 86% reduction in diabetic foot ulcer recurrence in clinical studies. The business model revolves around selling these high-tech insoles directly to consumers and healthcare providers, as well as offering data analytics services to researchers and practitioners. Revenue is generated through product sales and subscription-based data services.
Source: Dealroom company dataNews
Open roles
Orpyx Medical Technologies in the Calgary ecosystem
The Orpyx Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Thin Air Labs- PCPaddock Capital
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Orpyx Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Orpyx Medical Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


